Posted on May 8, 20265/8/26
How MFN is Reshaping Global Drug Pricing – and How NAVLIN Insights Tracks It
Posted on December 12, 202512/12/25
Consolidating Data Strategy For Global Success
Posted on December 10, 202512/10/25
Predicting PICOs for EU HTA: The Validated PICO Planner Approach Based on Retrospective Analysis
Posted on September 30, 20259/30/25
Strategic PICO Planning: Navigating Oncology Markets with NAVLIN by EVERSANA
Posted on September 20, 20249/20/24
RWEsearch 2024 | Innovating Clinical Trial Design with Real World Evidence
Posted on July 24, 20247/24/24
Evolving Standards: NICE’s Enhanced RWE Framework for Global Data Transportability
Posted on July 8, 20247/8/24
Report: Integrated Delivery Network Trends and Engagement Strategies Every Drug Manufacturer Needs to Know
Posted on July 2, 20247/2/24
The New AMCP Dossier Format Version 5.0: Key Implications for Strategic Approach
Posted on April 30, 20244/30/24
Decoding EMA’s Blueprint on Real-World Evidence
Posted on March 27, 20243/27/24